 ENGLEWOOD, Colo., April 29, 2021 PRNewswire -- 2021 First Quarter Revenue increased 58 year over year to 24.1 million Orders increased 140 Net loss of 0.7 million; GAAP loss per share 0.02 Adjusted EBITDA loss 0.4 million Zynex, Inc. NASDAQ: ZYXI, an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2021. 